XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 59 filers reported holding XENON PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,300,000 | +139.1% | 250,000 | +66.7% | 0.09% | +196.6% |
| Q2 2018 | $1,380,000 | +87.8% | 150,000 | 0.0% | 0.03% | +222.2% |
| Q1 2018 | $735,000 | +73.3% | 150,000 | 0.0% | 0.01% | +50.0% |
| Q4 2017 | $424,000 | -4.3% | 150,000 | 0.0% | 0.01% | -25.0% |
| Q3 2017 | $443,000 | -6.3% | 150,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $473,000 | -21.2% | 150,000 | 0.0% | 0.01% | -38.5% |
| Q1 2017 | $600,000 | – | 150,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $10,277,999 | 12.45% |
| COMMODORE CAPITAL LP | 1,845,000 | $71,032,500 | 7.98% |
| Altium Capital Management LP | 228,000 | $8,778,000 | 6.64% |
| TLS Advisors LLC | 33,756 | $1,300 | 5.58% |
| GREAT POINT PARTNERS LLC | 530,000 | $20,405,000 | 3.99% |
| DAFNA Capital Management LLC | 280,538 | $10,800,713 | 2.95% |
| Paradigm Biocapital Advisors LP | 989,327 | $38,089,090 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,403,630 | 2.81% |
| Avoro Capital Advisors LLC | 4,900,000 | $188,650,000 | 2.56% |
| Ghost Tree Capital, LLC | 185,000 | $7,122,500 | 2.35% |